Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1625 (LINC01625)

Target
LINC01625
Molecular classification
Long intergenic non-coding RNA (lincRNA), Non-coding RNA
01

Overview

LINC01625 is a long intergenic non-protein coding RNA gene, categorized as a lincRNA, which means it is a long RNA transcript (>200 nucleotides) that does not encode a protein and does not overlap with annotated protein-coding genes. LincRNAs, such as LINC01625, are known to function in the complex regulation of gene expression, sometimes acting at the level of chromatin architecture, RNA stabilization, or as regulatory signals. While the broader class of lincRNAs is established as playing roles in various physiological and pathological contexts, including cancer, there is limited direct functional or mechanistic information about LINC01625 itself. Some studies have implicated lincRNAs (including LINC01625) in regulation of the cell cycle and tumor biology, but LINC01625 is not currently a recognized therapeutic target. LINC01625 is a non-protein-coding RNA gene, not a protein target. It is not a receptor, enzyme, transporter, or a conventionally druggable target. It may play a regulatory role in gene expression and cancer biology—but specific validated functions remain sparse. No drugs, established mechanisms of action, or safety data are available for targeting LINC01625. This gene’s definition and function should not be confused with protein-coding genes or targets typically modulated by small molecules or biologics.

Other names
TCONS_00011139hCG1786283ENSG00000238099
02

Biological functions

Gene expression regulation (via RNA-based mechanisms)Possibly regulation of the cell cycle
03

Disease associations

Cancer (evidence associates LINC01625 with roles in cancer subtyping and possibly hepatocellular carcinoma)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1625 (LINC01625).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1625 (LINC01625).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call